CompletedNCT01903967

Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)

Studying Pituitary tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospices Civils de Lyon
Principal Investigator
Gérald RAVEROT, PhD - MD, M.D
Hospices Civils de Lyon
Enrollment
213 target
Eligibility
18-85 years · All sexes
Timeline
20132017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01903967 on ClinicalTrials.gov

Other trials for Pituitary tumor

Additional recruiting or active studies for the same condition.

See all trials for Pituitary tumor

← Back to all trials